OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 515.25M
Enterprise Value 39.58M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.69
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.83

Trading Information

Stock Price History

Beta (3Y Monthly) 0.24
52-Week Change 33.50%
S&P500 52-Week Change 36.69%
52 Week High 36.23
52 Week Low 31.60
50-Day Moving Average 33.55
200-Day Moving Average 32.72

Share Statistics

Avg Vol (3 month) 3147.92k
Avg Vol (10 day) 3637.46k
Shares Outstanding 556.47M
Float 2.45M
% Held by Insiders 18.89%
% Held by Institutions 112.72%
Shares Short (Jun 28, 2019) 4284.04k
Short Ratio (Jun 28, 2019) 44.23
Short % of Float (Jun 28, 2019) 411.04%
Short % of Shares Outstanding (Jun 28, 2019) 410.04%
Shares Short (prior month May 31, 2019) 4192.5k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Feb 4, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-18.45%
Return on Equity (ttm)-67.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.39M
Net Income Avi to Common (ttm)-8.94M
Diluted EPS (ttm)-3.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.13M
Total Cash Per Share (mrq)0.75
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.73
Book Value Per Share (mrq)3.18

Cash Flow Statement

Operating Cash Flow (ttm)-3.32M
Levered Free Cash Flow (ttm)-1.89M